Prestige Consumer Healthcare Inc. (PBH) stock
PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3021% below fair value
$50.62+2.40 (+4.98%)
Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –
Prestige Consumer Healthcare r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Prestige Consumer Healthcare
Prestige Consumer Healthcare has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?